ReleaseWire Connect

Femtocells are low power devices that are used to improve the mobile network coverage. These plug and play devices use a broadband connection to connect to the cellular operator. Femtocells improve the transmission of both voice and data, thus gained attention of the mobile subscribers. These devices can be used standalone or integrated along with other networks such as macro cell or Wi-Fi. The integrated use of these devices is increasing due to high operational performance. Femtocells are available for different networks such as 2G, 3G and 4G (LTE), however key players are focusing on the development of LTE femtocells. Poor network due to signal attenuation in buildings and continuous focus of operators to fill network gaps in urban areas are the major factors driving the market. However, the growth of LTE femtocells is expected to drive the demand in the coming years.

Over the past few years, technological innovations have revolutionized the electronics industry. Electronic products serve a wide range of areas such as environmental protection, security, communications, food supply, health, education and medicine. The increasing demand for electronic products has led to rise in electronic waste. However, only a small percentage of the global electronic waste is being recycled, while a large portion is often dumped into landfills. Inadequate public education and lack of awareness has further increased the recycling problem. More visibility in terms of collection methods, adequate support from the government and increased awareness among the consumers is expected to boost the electronics recycling market.

This report analyses the global market for active pharmaceutical ingredients for the period from 2012 to 2020. The market has been analyzed on the basis of type of API manufacturing (captive or in-house and contract manufacturing), type of active pharmaceutical ingredients (synthetic chemical API and biological API), type of drugs (branded or innovative prescription drugs, generic prescription drugs, and over-the-counter drugs), therapeutic areas, and by geography. The global API market is analyzed on the basis of therapeutic areas namely, NSAIDs, oncology drugs, diabetes drugs, cardiovascular drugs, central nervous system drugs, musculoskeletal drugs, and other drugs (such as antibacterial, antiviral, antifungal drugs, etc.). Also, the market for select NSAIDs (paracetamol, ibuprofen, aspirin, and naproxen) has alsbeen analyzed in detail in this report. The above mentioned segments are analyzed on the basis of market size in terms of USD million and their forecasts for the period 2014 to 2020 have alsbeen provided. The CAGR (%) for the segments have been estimated for the forecast period from 2014 to 2020, considering 2013 as the base year.

This report on tuberculosis testing studies the current as well as future prospects of the market globally. Tuberculosis (TB) is a highly contagious disease, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. People majorly suffer from two forms of TB: active tuberculosis and latent tuberculosis. The several types of TB based on the site of infection are pulmonary TB (lungs), skeletal TB (bone and joints), pleural TB, lymph node TB, gastrointestinal TB, and TB meningitis. Pulmonary TB is the most contagious disease and affects a large number of individuals globally. Based on types of tests, the tuberculosis testing market has been segmented into seven major categories: smear microscopy, culture-based tests, nucleic acid testing, Mantoux test or tuberculin skin tests (TST), radiography (chest x-ray), drug susceptibility testing (DST) and other TB tests.

Dilated cardiomyopathy is an important cause of heart failure and is one of the leading indications for heart transplantation across the globe. It is characterized by the enlargement of ventricular chamber along with systolic dysfunction. Dilated cardiomyopathy can develop at any age but it is more common among people aged between 20 years and 60 years. According to American Society for Clinical Investigation about 25% - 50% of the total dilated cardiomyopathy cases are genetically caused, owing to mutation in genes encoding for cytoskeleton, contractile, or other proteins in myocardial cells.

The orthopedic soft tissue surgical procedures market has been segmented into surgeries such as rotator cuff repair, vaginal prolapse, lateral epicondylitis, Achilles, gluteal tendon and anterior cruciate ligament. The orthopedic soft tissue surgical procedures market offers lucrative business opportunities in developed regions such as the U.S., Europe and Japan due to periodic launch of technologically advanced surgical products by key players and increasing number of injuries caused by sports such as basketball, football and baseball. For example, the American Orthopedic Society of Sport Medicine estimated that around 150,000 ACL injuries occur in the U.S. each year and the number of injuries is projected to increase in the near future. The aging population is at higher risk of developing orthopedic soft tissue injuries, and hence contributes significantly toward the expansion of the soft tissue repair market. The growing trend of minimally invasive surgeries and increasing number of patients opting for active lifestyle are also fueling the growth of the orthopedic soft tissue surgical procedures market. According to the United Nations, developed regions such as Europe and North America (the U.S. and Canada) have highest percentage of aging population and are expected to grow at a higher percentage in future. This would increase the number of patients undergoing orthopedic soft tissue repair surgeries, thereby boosting market growth. However, high cost of surgeries and availability of effective non-operative treatment options such as NSAIDS and casting material are anticipated to restrain market growth.

Pre-Owned medical devices are defined as the devices that were owned earlier by any healthcare institution and that are now subject to sale or repurchase after refurbishment. 'Refurbishment' is defined as restoration of the device to its original specifications including replacement of basic wear parts and aesthetic changes to a complete end-to-end refurbishment. The pre-owned medical devices market study is thus, of interest of the refurbishment service providers. This report exclusively studies the market for pre-owned medical devices from aspects such as value of the refurbishment services rendered, per medical device type. The pre-owned medical devices market is classified by the medical device type that is refurbished i.e. X-ray and Mammography Machines, CT Machines, MRI Machines, UltraSound Machines, Nuclear Imaging and Medicine Devices and C-arm Devices. The market size and forecast for the period 2013 – 2019, in terms of USD million, considering 2012 as the base year has been provided for each segment and sub-segment in the report. The compound annual growth rate (CAGR) for each segment has been provided for the forecast period from 2013 – 2019.

Neurological disorders-conditions that affect the nervous system-are on the rise, and so is the demand for treating these conditions. This, in turn, has given the demand for neurology devices a fillip. The market for neurology devices is currently in expansion mode, and this research report charts this growth path between 2013 and 2019.

Electrophysiology devices are used in the diagnosis and treatment of those diseases that occur due to abnormal electrical properties of biological cells and tissues. Electrophysiology devices have wide application in the management of cardiac arrhythmias. The study analyzes two major segments of the electrophysiology devices market namely, electrophysiology monitoring devices and treatment devices. The market for electrophysiology monitoring devices comprises for all those devices that are widely used in the diagnosis of atrial fibrillation, atrial flutter, ventricular tachycardia, epilepsy and retinal disorders. Electrophysiology monitoring devices are segmented as electrocardiograph, electroencephalograph, electroretinograph, electromyograph, electrocorticograph, electrooculograph, x-ray systems, imaging and 3D mapping systems, diagnostic electrophysiology catheters and Holter monitoring devices. The market for treatment devices includes pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices and catheters. The report also explains various technological advancements taking place in the segment.

The global mechanical ventilators market is expected to witness notable growth primarily because of rapid technological innovation in the design and portability of these devices and the rising prevalence of chronic respiratory disorders. In addition, increase in preference of cost deviation by hospitals by transferring long term ventilated patients to home care settings is expected to be another major factor spurring the demand for portable and home care mechanical ventilators. The global market for mechanical ventilation has come a long way since the past two decades and its growth is mainly attributed to the high demand for technologically advanced medical devices in developed markets.